BioMan4R2 Success stories IntegraSkin
IntegraSkin specializes in personalized therapy optimization for patients with Chronic Inflammatory Skin Conditions (CISCs). Leveraging advanced laboratory and molecular testing combined with AI and environmental monitoring through their KiDERM platform, ISK identifies the unique factors influencing each patient's condition. This approach enhances diagnostic accuracy, boosts treatment effectiveness, and lowers healthcare costs and the risk of side effects.
📢 “𝘉𝘪𝘰𝘔𝘢𝘯4𝘙2 𝘧𝘰𝘴𝘵𝘦𝘳𝘴 𝘢 𝘩𝘦𝘢𝘭𝘵𝘩𝘺 𝘳𝘪𝘴𝘬-𝘵𝘢𝘬𝘪𝘯𝘨 𝘮𝘦𝘯𝘵𝘢𝘭𝘪𝘵𝘺 𝘵𝘩𝘢𝘵'𝘴 𝘰𝘧𝘵𝘦𝘯 𝘮𝘪𝘴𝘴𝘪𝘯𝘨 𝘪𝘯 𝘌𝘶𝘳𝘰𝘱𝘦. 𝘉𝘺 𝘱𝘳𝘰𝘷𝘪𝘥𝘪𝘯𝘨 𝘵𝘩𝘦 𝘤𝘳𝘶𝘤𝘪𝘢𝘭 𝘭𝘦𝘢𝘱 𝘰𝘧 𝘧𝘢𝘪𝘵𝘩 𝘢𝘯𝘥 𝘳𝘦𝘴𝘰𝘶𝘳𝘤𝘦𝘴 𝘦𝘢𝘳𝘭𝘺-𝘴𝘵𝘢𝘨𝘦 𝘤𝘰𝘮𝘱𝘢𝘯𝘪𝘦𝘴 𝘯𝘦𝘦𝘥, 𝘪𝘵 𝘦𝘯𝘢𝘣𝘭𝘦𝘴 𝘵𝘩𝘦𝘮 𝘵𝘰 𝘵𝘦𝘴𝘵 𝘢𝘯𝘥 𝘳𝘦𝘧𝘪𝘯𝘦 𝘵𝘩𝘦𝘪𝘳 𝘮𝘰𝘥𝘦𝘭𝘴 𝘣𝘦𝘧𝘰𝘳𝘦 𝘴𝘦𝘦𝘬𝘪𝘯𝘨 𝘮𝘢𝘫𝘰𝘳 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵. 𝘉𝘪𝘰𝘔𝘢𝘯4𝘙2 𝘪𝘴 𝘢 𝘷𝘪𝘵𝘢𝘭 𝘦𝘹𝘢𝘮𝘱𝘭𝘦 𝘰𝘧 𝘣𝘳𝘦𝘢𝘬𝘪𝘯𝘨 𝘵𝘩𝘦 𝘧𝘶𝘯𝘥𝘪𝘯𝘨 𝘤𝘺𝘤𝘭𝘦 𝘵𝘩𝘢𝘵 𝘴𝘵𝘪𝘧𝘭𝘦𝘴 𝘌𝘶𝘳𝘰𝘱𝘦𝘢𝘯 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯, 𝘱𝘢𝘷𝘪𝘯𝘨 𝘵𝘩𝘦 𝘸𝘢𝘺 𝘧𝘰𝘳 𝘨𝘳𝘰𝘶𝘯𝘥𝘣𝘳𝘦𝘢𝘬𝘪𝘯𝘨 𝘢𝘥𝘷𝘢𝘯𝘤𝘦𝘮𝘦𝘯𝘵𝘴.”, a company representative says.
👉 Project Focus: KiDERM This project targets the regulatory, economic, and market entry challenges for Ki-DERM. Key objectives include:
✅ Regulatory Compliance: Achieving necessary certifications to ensure compliance.
✅Market Prospects: Enhancing sales potential and attracting venture capital investments.
✅Grant Applications: Securing successful grant funding.
Follow all BioMan4R2 success stories and achievements on LinkedIn!
Attachment | Size |
---|---|
Success story IntegraSkin | 1.08 MB |